Pharmaceutical composition for Inhalation comprising aclidinium, lactose, providing a dose of 322 UG Free Base and about 140 ug of aclidinium bromide; a method for treating a Respiratory condition selected Asthma and COPD; use of the composition, and an inhalation device Calibration that includes dry powder

摘要

A pharmaceutical composition for inhalation comprising aclidinium in the form of a dry powder of a pharmaceutically acceptable salt in admixture with a pharmaceutically acceptable dry powder carrier, providing a delivered dose of aclidinium equivalent to about 322 micrograms aclidinium free base.